Glucosamine and Restoril drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Glucosamine (glucosamine) and Restoril (temazepam). Common drug interactions include nausea among females and musculoskeletal disorder among males.

The phase IV clinical study analyzes what interactions people have when they take Glucosamine and Restoril. It is created by eHealthMe based on reports of 34 people who take the same drugs from the FDA, and is updated regularly.

What is Glucosamine?

Glucosamine has active ingredients of glucosamine. It is often used in joint pain. eHealthMe is studying from 15,547 Glucosamine users. Check the latest studies of Glucosamine.

What is Restoril?

Restoril has active ingredients of temazepam. It is often used in insomnia. eHealthMe is studying from 13,522 Restoril users. Check the latest studies of Restoril.



On Jul, 10, 2026

34 people who take Glucosamine and Restoril together, and have interactions are studied.

Glucosamine and Restoril drug interactions.

What are the common drug interactions of Glucosamine and Restoril, by gender? *:

female:

  1. Nausea (feeling of having an urge to vomit)
  2. Diarrhoea
  3. Drug ineffective
  4. Pruritus (severe itching of the skin)
  5. Sinusitis (inflammation of sinus)
  6. Asthenia (weakness)
  7. Burning sensation
  8. Headache (pain in head)
  9. Migraine (headache)
  10. Muscle spasms (muscle contraction)

male:

  1. Musculoskeletal disorder (disease of the body's muscles, joints, tendons, ligaments and nerves)
  2. Visual impairment
  3. International normalised ratio decreased
  4. International normalised ratio increased
  5. Platelet count decreased
  6. Staphylococcal infection (an infection with staphylococcus bacteria)
  7. Gastrointestinal disorder (functional problems of gastrointestinal tract)
  8. Abscess (pus)
  9. Cholelithiasis (the presence or formation of gallstones in the gallbladder or bile ducts)
  10. Confusional state

What are the common drug interactions of Glucosamine and Restoril, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

n/a

30-39:

n/a

40-49:

  1. Headache (pain in head)
  2. Infrequent bowel movements
  3. Restlessness (not able to rest)
  4. Somnolence (a state of near-sleep, a strong desire for sleep)
  5. Diarrhoea
  6. Nausea (feeling of having an urge to vomit)
  7. Migraine (headache)
  8. Muscle spasms (muscle contraction)
  9. Sinusitis (inflammation of sinus)
  10. Vomiting

50-59:

  1. Pain in extremity
  2. Tenderness (pain or discomfort when an affected area is touched)
  3. Abdominal distension
  4. Abdominal pain lower
  5. Aphasia (damage to the parts of the brain that control language)
  6. Asthenia (weakness)
  7. Back pain
  8. Blood pressure increased
  9. Cardiac disorder
  10. Cardiac failure

60+:

  1. Musculoskeletal disorder (disease of the body's muscles, joints, tendons, ligaments and nerves)
  2. Visual impairment
  3. Contusion (a type of hematoma of tissue in which capillaries)
  4. Dizziness
  5. Drug ineffective
  6. Dyspnoea (difficult or laboured respiration)
  7. Fall
  8. Headache (pain in head)
  9. Hyperhidrosis (abnormally increased sweating)
  10. International normalised ratio decreased

What are the existing conditions these people have? *

  1. Pain: 5 people, 14.71%
  2. Multiple Myeloma (cancer of the plasma cells): 4 people, 11.76%
  3. Sleep Disorder: 3 people, 8.82%
  4. Rheumatoid Arthritis (a chronic progressive disease causing inflammation in the joints): 3 people, 8.82%
  5. Parkinson's Disease: 3 people, 8.82%
  6. Neuropathy Peripheral (surface nerve damage): 3 people, 8.82%
  7. Immunodeficiency Common Variable: 3 people, 8.82%
  8. Fibromyalgia (a long-term condition which causes pain all over the body): 3 people, 8.82%
  9. Transient Ischaemic Attack (a transient episode of neurologic dysfunction caused by ischemia (loss of blood flow)): 2 people, 5.88%
  10. Gastroesophageal Reflux Disease (a condition in which stomach contents leak backward from the stomach into the oesophagus): 2 people, 5.88%

* Approximation only. Some reports may have incomplete information.

Do you take Glucosamine and Restoril?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously



Related studies:

Effectiveness of, side effects of, and alternative drugs to the 2 drugs:

Browse all drug interactions of Glucosamine and Restoril:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Sub-studies by gender and age:

Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Browse all side effects of Glucosamine:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all side effects of Restoril:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Glucosamine and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Restoril and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

How the study uses the data?

The study uses data from the FDA. It is based on glucosamine and temazepam (the active ingredients of Glucosamine and Restoril, respectively), and Glucosamine and Restoril (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.



Recent studies on eHealthMe: